A Useful Clinical Tool for Psoriasis

Abstract

Keywords

psoriasis PASI psoriasis area and severity index

Get full access to this article

View all access options for this article.

References

McInnes

IB.

O’Dell

. State-of-the-art: rheumatoid arthritis. Ann Rheum Dis. 2010;69(11):1898-1906.doi:10.1136/ard.2010.134684

20959326

American College of Rheumatology 20/50/70 criteria (ACR20/50/70) [Internet] . MRT ecommerce. [cited 2021Mar23]. https://eprovide.mapi-trust.org/instruments/american-college-of-rheumatology-20-50-70-criteria

Feldman

SR.

Krueger

. Psoriasis assessment tools in clinical trials. Ann Rheum Dis. 2005;64(suppl 2):ii65-ii68.doi:10.1136/ard.2004.031237

15708941

Sawyer

LM.

Cornic

Levin

L Å.

Gibbons

Møller

AH.

Jemec

. Long‐term efficacy of novel therapies in moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis of PASI response. J Eur Acad Dermatol Venereol. 2019;33(2):355-366.doi:10.1111/jdv.15277

30289198

Armstrong

AW.

Puig

Joshi

et al. Comparison of biologics and oral treatments for plaque psoriasis: a meta-analysis. JAMA Dermatol. 2020;156(3):258-269.doi:10.1001/jamadermatol.2019.4029

32022825

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.39 MB